中新网9月22日电 由中华医学会心血管病学分会心力衰竭学组、中国国家心血管病中心/阜外心血管病医院和中华心血管病杂志编委会联合主办的“2012年心力衰竭学术大会(第四届全国心力衰竭学术会议)”于22日在北京开幕。

Beijing on September 22 (xinhua) -- the Chinese medical association cardiovascular epidemiology branch young heart failure/China's national cardiovascular disease center/fortune recourse international hospital cardiovascular disease and the cardiovascular disease magazine editorial committee jointly organized"2012 heart failure academic conference(The fourth session of national heart failure academic conference)"In 22, opening in Beijing.

　　本届心力衰竭学术会议执行主席、阜外心血管病医院教授张建在开幕式上致辞。他说，在过去30年中，心力衰竭的基础和临床研究各个方面均取得很大成果，显著提高心力衰竭的诊治水平，改善了患者的预后，而且心衰的指南也根据最新的研究成果不断更新。当天，中华医学会心血管病学分会主任委员胡大一、中华医学会心血管病学分会常委兼心衰学组组长黄峻等也分别致辞。随后，多名专家学者就心力衰竭的诊治进展、防治状况等发表专题报告。

The heart failure academic conference executive chairman/Fortune recourse international cardiovascular disease hospital professor ZhangJian make a speech on the opening ceremony.He said,In the past 30 years,,The heart failure in basic and clinical research of each aspect has achieved great results,Improve the level of diagnosis and treatment of heart failure,To improve the prognosis of the patients,And heart failure guideline also according to the latest research results constantly updated.The day,The Chinese medical association cardiovascular epidemiology branch b the chairman of the committee/The Chinese medical association cardiovascular epidemiology branch and heart failure of young leader HuangJun also gave speeches.then,More than experts and scholars will progress the diagnosis and treatment of heart failure/State of the prevention and control of published reports.

　　本次大会邀请到了100余位知名专家学者，来自美欧的心血管病专家介绍了发达国家在心力衰竭的诊断和治疗方面的最新进展，中国多名专家就心力衰竭的诊断方法、新的治疗药物、非药物治疗方法、心力衰竭合并症的治疗进展等多个方面进行深入交流。

The conference invited to the more than 100 well-known experts and scholars,The us and Europe from cardioascular disease expert introduction in the developed countries the diagnosis and treatment of heart failure as the latest progress,China expert is heart failure diagnosis method/New drugs/Non-drug therapy method/Heart failure progress in treatment of complications and so on many aspects of the thorough exchange.

　　本届会议内容包括36个心力衰竭临床医疗专题，16个心力衰竭基础研究专题，还有中国多个著名医院的典型心力衰竭病例报告。内容涵盖了对心力衰竭的新认识、新的诊断方法、新的治疗药物、特殊治疗如器械治疗和心脏移植等各个方面。

The conference contents including 36 heart failure clinical medical treatment project,16 heart failure basic research project,There are many famous Chinese hospital typical heart failure case report.The content covers the new understanding of heart failure/A new diagnosis method/New drugs/Special treatment such as instrument treatment and heart transplantation, etc.

　　据悉，心脑血管病是中国居民的首位死亡原因，其中心力衰竭是最严重的心血管疾病，心力衰竭发病后5年病死率超过50%，高于常见的恶性肿瘤。

It is reported,Is a Chinese resident cardio-cerebrovascular disease the first cause of death,The heart failure is the most serious cardiovascular disease,Heart failure incidence after five years case fatality rate more than 50%,Higher than common malignant tumor.

　　目前，中国对晚期心力衰竭进行心脏移植治疗已达到国际先进水平。中国国家心血管病中心阜外医院在近8年时间内进行心脏移植300多例，心脏移植患者的5年生存率接近90%，高于发达国家，且研制出具中国自主知识产权的心脏机械辅助装置。(完)

At present,China's late-stage heart failure heart transplant therapy has reached the international advanced level.China's national cardiovascular disease fortune recourse international center hospital in nearly eight years of time within which the heart transplant more than 300 cases,The heart transplant patients survival rate in 5 years of close to 90%,Than developed countries,Developed and issued by China's independent intellectual property rights of the heart mechanical auxiliary device.(finish)